WHO to support OpenAccess to Clinical Trials Data

Dear Friends Here is an excellent development in AllTrials, the international campaign that aims to transform the way scientists, universities and industries perform clinical trials. The campaign has operated for 2 years to make the world aware of the problem in data transparency in clinical studies. Reports indicates that between 50-30% of clinical studies do not report their […]

AllTrials Goes Viral with a Video Campaign

Following the crowdfunding campaign lunched at the end of last year, the OpenAccess movement AllTrial wants to get viral with a video that shows the bad side of medical research: the “publication bias”. AllTrial is a no-profit organization which tries to sensitize the public, the doctors and the policy makers about the huge, uncontrolled problem of unpublished Clinical Trials. […]

Letter to the European Medical Agency: release clinical trials data

Clinical trials are the very heart of modern medicine. Every time we want to know if a new drug discovered in labs is effective, we conduct a “simple” Randomized Controlled Trial (RCT), a fascinatingly basic experiment known to humans since biblical time. RCTs are a very potent tools to help patients, doctors and regulatory bodies to understand […]

Pharma must register trials and disclose results: why it matters

In science, policy and economy, unflattering data get often disregarded. If, as a scientist, your experiment does not support your initial hypothesis, you can do two things: repeat it until it satisfies you and publish it, or acknowledge the fact that your hypothesis may have a flaw. Wise researchers often opt for the second option, and give themselves the […]

Randomized Control Trials in Policy

“With the best of intention, policy can inflict pain or unnecessary extra cost to people, even thought they are moved with the best intention”. In this set of interviews, Ben Goldacre explores the possibility to apply to policy what has been applied (rather successfully) in medicine: Randomized Control Trials (RCTs). Ethical concerns, political power loss and embarrassment are all worth the […]